May 2017

NCI Standard Funding Opportunity Announcements

Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates


CDMRP Pre-Announcements for 2017
To be Announced See Links Below Federal Breast/Ovarian

CDMRP
Breast Cancer Research Program (BCRP)
Ovarian Cancer Research Program (OCRP)
Prostate Cancer Research Program (PCRP) &
Lung Cancer Research Program (LCRP)
FY17 Pre-announcements

Descriptions of the initiatives planned for these programs can be found at the links below.  The pre-announcements allow investigators time to plan and develop ideas for submission to the anticipated FY17 funding opportunities.
Contact: Office of Sponsored Research (x6804)
Program Links: Breast Cancer Research Program  
Ovarian Cancer Research Program
Prostate Cancer Research Program
Lung Cancer Research Program


Open All Ranks Non-federal Clinical Trials

The Gateway for Cancer Research
Research Grants

 
Gateway focuses on transformational science via effective clinical trials - when basic science translates into human testing and clinical practice.
Due Dates: Rolling requests for funding conducted in two stages: a Letter of Intent (LOI) and if invited, a full application. Applicants must submit via Gateway's Grant Management System  
Amount & Project Period: Funding is variable and duration is 1 to 3 years
Eligibility: All Ranks
Contact: Gateway Contacts are: Jerian Dixon-Evans, Research Grants Specialist  Jerian.Dixon-Evans@gatewaycr.org (847) 342-7361 and Domarina Oshana, Ph.D., Director of Research and Grants Domarina.Oshana@gatewaycr.org (847) 342-7443
Link: Grant Application Process

Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding.
Due Dates: Open until Mar. 31, 2017
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: ARO CORE BAA-W911NF-12-R-0012-Mod 03


NEW
Ongoing Postdocs/Junior Faculty Non-federal Pediatric Brain Tumors

A Kids' Brain Tumor Cure Foundation (aka The PLGA Foundation)
Research Grants

Proposals related to basic and translational projects that can advance understanding of the underlying biology of the development and treatment of pediatric low grade glioma brain tumor (PLGA) tumors will be considered.
Due Dates: Letters of Intent are accepted on an ongoing basis, and are reviewed by an expert panel. Based on this feedback, selected applicants will be invited to submit a full proposal
Amount & Project Period: Funding is based on size, complexity, and potential impact of project, and can be awarded over a one-, two-, or three-year period.
Eligibility: Investigators in the early years of their careers are encouraged to apply.  
Contact: Office of Sponsored Research (x6804)
Link: Apply for an AKBTC Sponsored Grant
September 30, 2017 All Ranks Federal Medical Research


Department of Defense - Dept. of the Army - USAMRAA
DoD USAMRMC FY17 Broad Agency Announcement
for Extramural Medical Research
XW1XWH-17-R-BAA1

Projects funded under this BAA must be for basic and applied research to support scientific study and experimentation directed towards advancing the state of the art or increasing knowledge or understanding rather than focusing on development of a specific system or hardware solution.
Due Dates: This Broad Agency Announcement (BAA) is open from October 1, 2016 through September 30, 2017, 11:59 p.m., ET. Pre-proposals are required so that the Government can determine whether a proposed research idea meets USAMRMC's mission and requirements. Pre-proposals may be submitted at any time during the 12-month period.  To submit a full proposal/application, the PI must have received an invitation to submit from a Contracting or Grants Officer.
Amount & Project Period: No  funding limitations specified - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: W81XWH-17-R-BAA1

NEW
See Below Postdocs Non-federal Poster/Travel Awards - Lymphatic

Lymphatic Education & Research Network
Lymphatic Forum 2017 Travel and Poster Awards

LE&RN is proud to co-host and sponsor Lymphatic Forum 2017 in Chicago, June 8-10, 2017.  Over 30 internationally renowned scientists will come together to discuss research in basic and disease-oriented areas of lymphatic and vascular biology including therapeutic approaches
Due Dates: See website
Amount & Project Period: Travel Awards:  $500 to defray costs of attendance at the Lymphatic Forum 2017-Exploring the Lymphatic Continuum. Best Poster Presentation Awards:  one for $1,000 and three for $500.
Eligibility: Young investigators who are LE&RN Supporting Members (PhD students, medical students and postdocs).
Links: Travel & Poster Awards
Various NCI

NEW
Multiple See Below Federal Cancer Moonshot

Cancer Moonshot - Funding Opportunities

NCI has identified funding opportunity announcements (FOAs) from within its extensive research portfolio that address the goals of the Cancer Moonshot.   This portfolio will expand over the next 7 years.  Planning for implementation of longer-term scientific initiatives is underway.  Multiple ways to fund the best science, including grants, supplements and other mechanisms are being considered.
Due Dates: Multiple - See specific FOA
Amount & Project Period: See specific FOA
Eligibility: See specific FOA
Contact: Office of Sponsored Research (x6804)
Link: Cancer Moonshot Funding Opportunities

April 20 (LOI) All Ranks Federal Clinical Effectiveness

Patient Centered Outcomes Research Institute (PCORI)
Pipeline to Proposal Awards Tier A Pre-Engagement/Community Projects

The purpose of the Pipeline to Proposal (P2P) Awards program is to help people form new collaborations with the goal of developing proposals for research with sound scientific rigor and robust patient engagement.  We are interested in research teams that include patients, caregivers, clinicians, and other healthcare stakeholders, as well as researchers.  The P2P program now has two tiers. The first (Tier A) is designed to support the development of research partnerships as they identify a comparative clinical effectiveness research (CER) question (or series of questions) that is important to patients, researchers, and other members of the healthcare community.
Due Dates: Apr. 20 (Letter of Intent)
Amount & Project Period: $50,000 -1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Key Information Ι Application Guidelines
R21 NIH
NCI is a participating Institute
April 23 (LOI) All Ranks Federal Liver

Mechanisms of Disparities in Chronic Liver Diseases and Cancer

The purpose of the initiative is to support multidisciplinary research to understand the underlying etiologic factors and the mechanisms that result in disparities in chronic liver diseases and cancer in the US.
Due Dates: Apr. 23 (Letter of Intent)
May 18 (OSR) Ι May 22 (Sponsor)
Additional Due Dates: Apr. 4, 2018, Apr. 4, 2019
Amount & Project Period: $275,000 - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-150
Companion FOA: PAR-17-151 (R01)

April 24 All Faculty Ranks Non-federal Prostate

Prostate Cancer Foundation
2017 PCF Challenge Awards for Metastatic, Lethal Prostate Cancer

Awards are for investigations of metastatic, lethal prostate cancer. Awards will be funded depending on the level of innovation in applications received. High risk, currently unfunded projects are most desired.
Due Dates: Apr. 20 (OSR) Ι Apr. 24 (Sponsor)
Online application submission portal live at https://pcf.smartsimple.com as of  Friday, February 10th)
Amount & Project Period: $1 million per team - 2 years
Eligibility: Team should be composed of at least 3 highly experienced investigators and may be assembled from one or more institutions;
Team must include at least one young investigator as an integral contributor. (Young investigator may be Postdoc, Instructor, Research Associate, Asst. Professor, or equiv. and sh/be w/in 6 years of completing a professional degree or clinical training, and have received <$200,000 in current direct research funding from all sources including institutional funds.)
Contact: Office of Sponsored Research (x6804)
Links: RFA | Challenge Awards


NEW
April 25 Postdocs/Junior Faculty Non-federal Career Development

Multiple Myeloma Research Foundation(MMRF)
2017 Research Fellow Award

This initiative supports researchers at the post doctorate/medical fellow or junior faculty levels working under the supervision or guidance of a research mentor in the multiple myeloma field. The goal is to help support young investigators begin studies in the field of multiple myeloma while advancing the understanding of myeloma disease biology, treatment and drug resistance.
Due Dates: Apr. 21 (OSR) Ι Apr. 25 (Sponsor)
Amount & Project Period: $75,000 - 1 year
Eligibility: Researchers w/a Ph.D., M.D. or equivalent degree at the post-doctorate, clinical fellow, or junior faculty level are encouraged to apply.
Contact: Office of Sponsored Research (x6804)
Link: proposalCENTRAL (Guidelines  & application site)
U01 NCI


April 26(LOI) All Ranks Federal Screening

Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests

Applications are encouraged that develop and test multilevel interventions to improve follow-up to abnormal screening tests for breast, colorectal, cervical and lung cancers.  Appropriate applications should propose to intervene at one or more levels, and must measure outcomes at three or more levels, while accounting for interactions that occur between levels.
Due Dates: Apr. 26 (Letter of Intent)
May 24 (OSR) Ι May 26 (Sponsor)
Amount & Project Period: It is anticipated and encouraged that requests be in the range of $400,000 to $500,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-146
R01 NIH
NCI is a participating institute

NEW
April 27 (LOI) All Ranks Federal Nutrition

Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure

The purpose is to promote research on food specific molecular signatures and biomarkers of dietary consumption and to promote collaborative interactions among NIH and USDA supported nutrition researchers.
Due Dates: Apr. 27 (Letter of Intent)
May 25 (OSR) Ι May 27(Sponsor)
Additional Due Date:  Sept. 27, 2017
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-15-024


NEW
April 28 All Ranks Non-federal Head & Neck

Brandon C. Gromada Head & Neck Cancer Foundation
Research Awards

The awards are intended to stimulate innovative research regarding treatment and cures for head and neck cancers. Funds may be used by junior investigators to support ongoing, unfunded projects, or by senior investigators as seed money to launch new initiatives.
Due Dates: Apr. 26 (OSR) Ι Apr. 28 (Sponsor)
Amount & Project Period: $10,000 to $20,000
Eligibility: All levels of academic rank, including trainees (graduate students and post-doctoral fellows), junior faculty and established investigators.
Applicants must be actively engaged in head and neck cancer research
Contact: Office of Sponsored Research (x6804)
Links: 2017 RFP  Ι Brandon C. Gromada Head & Neck Cancer Foundation


NEW
April 28 (LOI) See Below Non-federal Ovarian

Ovarian Cancer Research Fund Alliance (OCRFA)
2018 OCRFA Grants

Due Dates: Apr. 28 (Letter of Intent)
Invited Applications:  Jul. 06 (OSR) Ι Jul. 10 (Sponsor)
Contact: Office of Sponsored Research (x6804)
Links: ProposalCENTRAL (Submission Site & Current Guidelines)
OCRFA Grant Programs

Collaborative Research Development Grants

Provide funds for large ovarian cancer research projects involving several investigators seeking to develop program project grant applications for submission to peer-review funding agencies.
Amount & Project Period: $900,000 - 3 years
Eligibility: Must have full time faculty appointment
 

Liz Tilberis Early Career Awards

For junior faculty with a strong commitment to an investigative career in the field of ovarian cancer research.
Amount & Project Period: $450,000 - 3 years
Eligibility: Must have an M.D. or Ph.D. and should be in first 5 years of first academic appointment (Assistant Professor or equivalent). Individuals who will begin such a position by July 2017 are eligible.
Investigator and institution must certify that at least 75% of the scholar's time will be dedicated to ovarian cancer research.

Ann Schreiber Mentored Investigator Award

Funds post-doctoral trainees working in ovarian cancer research groups or those currently enrolled in a fellowship program.
Amount & Project Period: $75,000 - 1 to 2 years
Eligibility: Applicants must be clinical fellows (Gynecologic Oncology, Medical Oncology), or post-doctoral fellows;
PhD applicants must be no more than 5 years beyond terminal degree at time of application (e.g. terminal degree awarded during 2012 or later);
MDs must be currently enrolled in a fellowship program; Although trainee may take part in some non-research activities, at least 90% effort should be devoted to research during term of award.


April 30 All Ranks Non-federal Research Projects

Elsa U. Pardee Foundation
Research Grants

The Foundation funds research directed toward identifying new treatments or cures for cancer, and particularly encourages applications  allowing establishment of capabilities of new cancer researchers, or new cancer approaches by established cancer researchers.  Project relevance to cancer detection, treatment, or cure should be clearly identified.
Due Dates: Apr. 27 (OSR) Ι Apr. 30 (Sponsor)
Additional 2017 Due Date:  Aug. 31st
Amount & Project Period: No limits stated; must be reasonably & clearly supported by scope of project in application - 1 year suggested
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Grant Application Process
R01 NCI

April 30 (LOI) All Ranks Federal Imaging

Perception and Cognition Research to Inform Cancer Image Interpretation  

The purpose is to facilitate research on the perceptual and cognitive processes underlying the performance of cancer image observers in radiology and pathology, in order to improve the accuracy of cancer detection and diagnosis.
Due Dates: Apr. 30 (Letter of Intent)
May 25 (OSR) Ι May 30 (Sponsor)
Additional 2017 Due Date:  September 26th
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact:  Office of Sponsored Research (x6804)
FOA Link: PAR-17-125
Companion FOA: PAR-17-124 (R21)


NEW
May 01 (Concept Paper) All Ranks Non-federal Reproductive  Health

The Lalor Foundation
The Anna Lalor Burdick Grants Program

This grant program seeks to empower young women through education about healthy reproduction in order to broaden and enhance their options in life.  The program focuses particularly on young women who have inadequate access to information regarding sexual and reproductive health, including comprehensive and unbiased information on contraception and pregnancy termination.
Due Dates: May 1 (Concept paper- online portal will open one month prior to concept paper deadline.)  Applicants invited to submit a full proposal will receive a full set of instructions to assist in preparation of a full online proposal.
Additional Date for Concept Paper:  Nov. 1
Amount & Project Period: $15,000 - $25,000  - 1 year (On rare occasions, trustees invite follow-up work to a project that has shown outstanding results or promise during its first year.)
Eligibility: All Ranks
Contact: Office of Sponsored Research - (x6804)
Link: Application Guidelines Ι Application Instructions


NEW
May 01 All Faculty Non-federal Research Project

American Society of Hematology
The Bridge Grants program

ASH is accepting proposals from hematologists whose research would not otherwise be accomplished due to cuts in funding from the National Institutes of Health. Established in January 2013, the long-term goal of the program is to help sustain recipients' research and keep them engaged in hematology investigation.
Due Dates: Apr. 27 (OSR) Ι May 01 (Sponsor)
Amount & Project Period: $150,000 - 1 year
Eligibility: Must hold a faculty position.
Must have submitted a hematology-related R01 or equiv. application to NIH in the past 18 (eighteen) months that was scored but not funded.
ASH membership is required at time of application and throughout award period.
Contact: Office of Sponsored Research (x6804)
Link: ASH Bridge Grant Program
R01 NIH
NCI is a participating Institute
NEW
May 06 (LOI) All Ranks Federal Chronic Pain

Clinical Evaluation of Adjuncts to Opioid Therapies for the Treatment of Chronic Pain

This FOA aims to fund applications designed to assess the clinical value of adjuncts prescribed to chronic pain patients together with opioid analgesics. Adjuncts of interest are either approved by the FDA or have previously been studied as an Investigational New Drug. Studies with adjuncts of interest should be focused on enhancing analgesia, rather than on reducing an adverse effect. A secondary purpose is to increase awareness among opioid prescribers of the potential value of adjunctive therapies by focused data dissemination.
Due Dates: May 06 (Letter of Intent)
June 03 (OSR) Ι June 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Application budgets not limited - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-14-225
R01 NIAID

May 07 All Ranks Federal Natural Killer (NK) Cells

NK Cells to Induce Immunological Memory to Prevent HIV Infection

The purpose is to support multidisciplinary, hypothesis-driven research on Natural Killer (NK) cells, leading to the discovery of pathways relevant for early immune responses and immune regulation impacting the potential protective immunity to be induced by HIV vaccination.
Due Dates: May 04 (OSR) Ι May 07 (Sponsor)
Additional Due Dates:  Standard Aids Dates
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-114
R33 NIH

NEW
May 10 All Ranks Federal Moonshot Initiative

Integration and Validation of Emerging Technologies to Accelerate Cancer Research

This FOA, associated with the Beau Biden Cancer Moonshot Initiative, is intended to accelerate cancer research. Specifically, this FOA targets the following 4 areas designated as scientific priorities:
1.  Enhanced experimental and analytical capabilities addressing complexities of cancer development;
2.  New capabilities advancing precise clinical diagnosis of cancer patients;
3.  Novel predictive ex vivo and/or in silico modeling approaches; and
4.  New technologies/approaches to improve biospecimen and data quality. Applications must be focused on one of these areas and must be based on comprehensive preliminary data substantiating the potential of the proposed technologies/tools/capabilities and the functionality their contributing components.
Due Dates: May 08 (OSR) Ι May 10 (Sponsor)
Amount & Project Period: $325,000/yr. (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-023
U01 NCI

May 10 (LOI) All Ranks Federal Glycomics

Alliance of Glycobiologists for Cancer Research: Translational Tumor Glycomics Laboratories

NCI encourages research projects to elucidate how changes in cellular carbohydrates may promote cancer initiation and progression and use this information to identify glycan-based abnormalities to serve as biomarkers for early cancer detection or risk assessment. 
Due Dates: May 10 (Letter of Intent)
Applications Due:  June 06 (OSR) Ι June 08 (Sponsor)
Amount & Project Period: Anticipated and encouraged are requests up to a maximum of $500,000/year (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-206
Companion FOA: PAR-17-207, U01


NEW
May 16 Postdocs/Junior Faculty Non-federal Career Development

Robert Wood Johnson Foundation
New Connections: Increasing Diversity of RWJF Programming

New Connections is a career development program for early career researchers, providing support to grantees and other individuals who are part of a network of eligible researchers. The researchers in this program come from multiple disciplines and work to build the case for a Culture of Health with strong qualitative and quantitative research skills; and produce and translate timely research results.
Due Dates: May 12 (OSR) Ι May 16 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: Must have completed doctoral degree w/in last 10 years (September 1, 2007 or later) and must be early-career scholars, such as a post-doc or assistant professor;
Must be from a group that has historically been disadvantaged or underrepresented in research disciplines. Eligible individuals include individuals from ethnic and racial groups historically underrepresented in research disciplines, first-generation college graduates, people from low-income communities, and individuals with a learning or physical disability.
See Call for additional details of eligibility
Contact: Office of Sponsored Research (x6804)
Link: 2017 Call for Proposals
U54 NIH
NCI is a participating Institute

NEW
May 19 (LOI) All Ranks Federal Tobacco Research

Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act

The purpose is to invite applications for Tobacco Centers of Regulatory Science (TCORS) to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP).
Due Dates: May 19 (Letter of Intent - LOI is due 60 days prior to the application due date)
Applications Due:  Jul. 17 (OSR) Ι Jul. 19 (Sponsor)
Amount & Project Period: Not to exceed $4 million/yr. (Total Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-OD-17-006
Companion RFA: RFA-OD-17-002, U54 Specialized Center-                                 Cooperative Agreements
R01 NIH

May 19 (LOI) All Ranks Federal Head & Neck

Neoantigen-Based Therapeutic Targeting of Head and Neck Cancers

The purpose of this FOA is to support basic and preclinical research aimed at developing novel immunotherapeutic targets for head and neck cancers (HNC), including salivary gland cancers. Research will identify human HNC-specific neoantigens, and will test the utility of these neoantigens as targets for eliciting anti-tumor immune responses in affected patient populations.
Due Dates: May 19 (Letter of Intent)
Applications Due:  June 15 (OSR) Ι June 19 (Sponsor)
Amount & Project Period: Limited to $350,000 in direct costs - 5  years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-DE-18-004


May 19 (Initial Proposal) All Faculty Ranks Non-federal MDS

The Taub Foundation
Grants Program for MDS Research

This program supports high-impact, innovative, translational research to understand the underlying causes of MDS and to advance its treatment and prevention. Innovative studies with transformative potential to elucidate MDS etiology and to develop new treatments are particularly encouraged.
Due Dates: Initial Proposal: May 17 (OSR) Ι May 19 12:00 Noon, EDT 
                                                         (Sponsor)
Invited Submissions:  Sept. 13 (OSR) Ι Sept. 15 (Sponsor)
Amount & Project Period: $600,000 - 3 years
Eligibility: All Faculty Ranks
U.S. citizenship not required; no visa documentation required
Contact: Office of Sponsored Research (x6804)
Link: Application Materials


May 22 All Ranks Non-federal Pediatric

Alex's Lemonade Stand Foundation for Childhood Cancer
2017 Reach Grants

This grant is intended to support selected late translational studies.  Preference will be given to research projects which will likely result in initiation of a clinical trial two to three years from the start of the project. 
Due Dates: May 18 (OSR) Ι May 22 (Sponsor)
Amount & Project Period: $250,000 - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: 2017 Reach Grants Ι Information for Grant Applicants
R21 NIH

May 30 (LOI) All Ranks Federal NCI Provocative Questions

Research Answers to NCI's Provocative Questions

The purpose is to support research projects designed to solve specific problems and paradoxes in cancer research identified by the National Cancer Institute (NCI) Provocative Questions initiative.  Each application must address one and only one specific PQ, exactly as defined in FOA.
Due Dates: May 30 (Letter of Intent)
Applications Due:  June 26 (OSR) Ι June 28 (Sponsor)
Additional 2017 Due Date:  Oct. 30
Amount & Project Period: $275,000 - 2 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-018 
Companion RFA: RFA-CA-17-017 (R01)
U01 NCI
RFAs also listed below for R01, P01 and P50 awards

NEW
May 30 (LOI) All Ranks Federal NCI Provocative Questions

Revision Applications to National Cancer Institute (NCI)-supported U01 Awards to Include Research on the NCI's Provocative Questions

This FOA invites revision applications from investigators with active NCI U01 research project awards. These revision applications are expected to focus on research related to one of the 12 of the NCI's Provocative Questions (PQs) published for new applications in RFA-CA-17-017 (R01) and RFA-CA-17-018 (R21) (See Above).  Research is encouraged that directly addresses PQs, including research that helps validate PQ research outcomes or adopt and disseminate PQ research results that impact cancer research and clinical care.
Studies proposed in the revision applications must correspond to additional specific aims, expanding the scope of individual, already funded projects of the parent U01 award. 
Due Dates: May 30 (Letter of Intent)
Applications Due: June 26 (OSR) Ι June 28 (Sponsor)
Additional 2017 Due Date:  Oct. 30
Amount & Project Period: Not to exceed $150,000/yr.(Direct Costs)
May request support for up to two years, not to exceed remaining number of years on parent grant. Parent grant must be active when application is submitted.
Eligibility: The PD/PI (or Contact PD/PI for multi-PD/PI awards) on the parent award must remain the same on the revision application.
If a no-cost extension is needed on the parent grant, it must be in place before the revision application is submitted.
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-CA-17-020
Companion RFAs: RFA-CA-17-019, Revision applications for R01 Research Project Grant
RFA-CA-17-021, Revision applications for P01 Research Program Projects
RFA-CA-17-022, revision applications for P50 Specialized Center
R01 NCI

May 30 (LOI) All Ranks Federal Imaging - CTs

Early Phase Clinical Trials in Imaging and Image-Guided Interventions

This FOA is intended to support clinical trials conducting preliminary evaluation of the safety and efficacy of imaging agents, as well as an assessment of imaging systems, image processing, image-guided planning and/or execution therapy, contrast kinetic modeling, 3-D reconstruction and other quantitative tools.
Due Dates: May 30 (Letter of Intent)
Applications Due:  June 26 (OSR) Ι June 28 (Sponsor)
Additional 2017 & 2018 Due Dates: Oct. 11; and Feb. 14; June 28, & Oct. 11, 2018
Amount & Project Period: $500,000 (Direct Costs) for total period.  No more than $250,000 (Direct Costs) may be requested in any single year. - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-167

May 31 All Ranks Non-federal Ovarian

Tell Every Amazing Lady Louisa M. McGregor Ovarian Cancer Foundation
2017 T.E.A.L.® Medical Research and Awareness Program Beneficiary

The Tell Every Amazing Lady About Ovarian Cancer Louisa M. McGregor Ovarian Cancer Foundation 2017 Medical Research Program offers funding in support of ovarian cancer research studies that are most aligned with that mission as determined by the T.E.A.L.® board of directors and scientific advisory board. The mission of the T.E.A.L.® is to promote public awareness of and education about the signs, symptoms, and risk factors of ovarian cancer, provide support to survivors, and raise funds for research in order to find a cure.
Due Dates: May 29 (OSR) Ι May 31 (Sponsor)
Amount & Project Period: $60,000/year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Links: Overview Ι RFP


NEW
May 31 Postdocs/Junior Faculty Non-federal Biomedical Science Prize

Vilcek Foundation
Prizes for Creative Promise in Biomedical Science

The Vilcek Foundation will award prizes to young foreign-born biomedical scientists who demonstrate outstanding early achievement. Eligible work may be in basic, applied, and/or translational biomedical science.
Due Dates: May 31 (Sponsor)
Amount & Project Period: $50,000  Unrestricted Cash Prize
Eligibility: Must have been born outside the U.S. and be no more than 38 years old as of December 31, 2017.
Must be a naturalized citizen or permanent resident (green card holder) of the U.S.; hold an H1B or O-1 visa and have been living & working in the U.S. for at least 5 years; or have been granted Deferred Action for Childhood Arrivals (DACA) status. Must have earned a doctoral degree (M.D., Ph.D., or equiv.), intend to pursue a professional career in the U.S., and hold a full-time position at an academic institution or other organization.
Link: Overview/Online Application
S10 NIH

Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs (ORIP)
May 31 See Below Federal Equipment

Shared Instrumentation Grant (SIG) Program

This FOA encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems. Types of instruments supported include, but are not limited to: X-ray diffractometers, mass and nuclear magnetic resonance (NMR) spectrometers, DNA and protein sequencers, biosensors, electron and light microscopes, cell sorters, and biomedical imagers.
Due Dates: May 26 (OSR) Ι May 31 (Sponsor)
Amount & Project Period: Maximum award is $600,000 - 1 year
Eligibility: PD/PI should have documented (in the biographical sketch) technical expertise directly related to the type of the chosen instrument. PD/PI does not need to have an NIH research grant or any other research support, but is expected to be an expert on the requested instrument. PD/PI may be a Core director, tenured, or non-tenured faculty member of the applicant organization.  Multiple PDs/PIs are not allowed.
Three Major Users (w/active NIH research awards) having a substantial need for the instrument must be identified. Once this eligibility requirement has been met, additional users with active research awards from NIH or other sources may be added as Major or Minor Users
Contact: Office of Sponsored Research (x6804)  
FOA Link: PAR-17-074


NEW
June 01 Postdocs/Junior Faculty Federal Career Development

Air Force Office of Scientific Research
Fiscal Year 2018 Air Force Young Investigator Research Program (YIP)
Broad Agency Announcement (BAA) BAA-AFRL-AFOSR-2017-0002

This program intends support for scientists and engineers demonstrating exceptional ability and promise for conducting basic research. The program objective is to foster creative basic research in science and engineering and enhance early career development of outstanding young investigators.
Due Dates: May 30 (OSR) Ι June 01(Sponsor)
Amount & Project Period: $450,000 - 3 years
Eligibility: Received PhD or equiv. April 1, 2012 or later;
OR
Received PhD or equiv. bet.  April 1, 2010 & April 1, 2012, and presently hold a tenure-track faculty position <2 years before April 1, 2017.
Must be a U.S. citizen, national, or permanent resident.
Contact: Office of Sponsored Research (x6804)
Link: BAA-AFRL-AFOSR-2017-0002
Admin. Supplements NCI

NEW
June 01 See Below Federal See Below

National Cancer Institute Administrative Supplements

Due Dates: May 30 (OSR) Ι June 01 (Sponsor)
Contact: Office of Sponsored Research (x6804)

Supplements for Validating the Use of Automated Sources of Residential Histories in Cancer Epidemiology Cohorts

NCI announces an opportunity for awardees holding eligible NCI-funded awards to request administrative supplement funding to support augmented efforts to refine automated methodologies to obtain more accurate and reliable lifetime residential history data and linkages that would enhance cancer research.
Amount & Project Period: Max. $125,000 (Total Costs) Project and budget periods must be w/in currently approved project period for existing parent award.  Supplements requests are limited to 1 year.  At least one full year must remain on the active grant or cooperative agreement award at time of funding.  Requests for no-cost extensions on parent grants to accommodate supplements will not be permitted.
Eligibility: To be eligible, the parent award must be active and the research proposed in the supplement must be accomplished within the competitive segment.  Eligible Award Types:  P01; R01; U01; UM1. Only one application per parent award is allowed.
FOA Link: PA-17-222
 

Supplement Opportunity to Support Population-Based Research Studies of Rare Cancers

NCI invites applications for supplemental funding to eligible NCI awards so that involved personnel (awardees) can advance their efforts to gain needed knowledge on rare cancers. The goal is to support population-based, hypothesis-testing studies that will increase  understanding of the etiology or post-diagnosis outcomes of rare cancers.
Amount & Project Period: Max. $150,000 (Total Costs) Project and budget periods must be w/in currently approved project period for existing parent award.  Supplements requests are limited to 1 year.  At least one full year must remain on the active grant or cooperative agreement award at time of funding. 
Requests for no-cost extensions on parent grants to accommodate supplements will not be permitted.
Eligibility: To be eligible, the parent award must be active and the research proposed in the supplement must be accomplished within the competitive segment.  Eligible Award Types:  P01; R01; R03; R21; U01; UM1.
Only one application per parent award is allowed.
FOA Link: PA-17-223
 

Research Supplements to Promote Sharing Data in Cancer Epidemiology Studies

Funds are available for administrative supplements to prepare and deposit individual-level data from cancer epidemiology studies into NCI-supported, controlled-access databases including the Cancer Epidemiology Data Repository (CEDR) and the database of Genotypes and Phenotypes (dbGaP).
Amount & Project Period: Max. $100,000 (Total Costs) Project and budget periods must be w/in currently approved project period for existing parent award.  Supplements requests are limited to 1 year.  At least one full year must remain on the active grant or cooperative agreement award at time of funding.  Requests for no-cost extensions on parent grants to accommodate supplements will not be permitted.
Eligibility: To be eligible, the parent award must be active and the research proposed in the supplement must be accomplished within the competitive segment.  Eligible Award Types:  P01; R01; R03; R21; U01; UM1.
Only one application per parent award is allowed.
FOA Link: PA-17-224
U01 NIH
NCI is a participating Institute

NEW
June 05 All Ranks Federal Health Behaviors

Intensive Longitudinal Analysis of Health Behaviors: Leveraging New Technologies to Understand Health Behaviors

 NCI is interested in supporting research in the following specific content areas:
     Projects that incorporate geospatial factors into data collection and analysis plans to account for data collection across diverse places.
     Incorporate data from multiple levels (e.g., biological, intrapersonal, interpersonal, community, policy) and types (e.g., self-report; sensor data) to explain and understand risky behaviors such as alcohol use, sedentary behavior, smoking, and poor diet.

Due Dates: June 01 (OSR) Ι June 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Limited to $500,000/yr. (Direct Costs) - 4 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-OD-17-004
Companion RFA: RFA-OD-17-005, U24 

R01 NIH
NCI is a participating Institute

NEW
June 05 All Ranks Federal Human Microbiome & Cancer

Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research

NCI encourages research on the microbiome and cancer, including the influence of pre/probiotics on functional and molecular profiles in cancer prevention, development and treatment.
Due Dates: June 01 (OSR) Ι June 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-15-135
Companion FOA: PA-15-127 Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01)
R01 NIAAA
NCI is a participating Institute

NEW
June 05 All Ranks Federal Alcohol-associated Cancers

Mechanisms of Alcohol-associated Cancers

The purpose is to invite applications investigating the cellular and molecular mechanisms by which alcohol increases cancer risk.  Research seeking to elucidate the mechanisms by which components of tobacco products, including ENDS interact with alcohol consumption to affect carcinogenesis is of high interest to NCI.
Due Dates: June 01 (OSR) Ι June 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-220
Companion FOA: PA-17-219, R21
R01 NCI

Reminder/Updates
June 05 All Ranks Federal See Specific FOA

New and/or Re-Issued NCI Funding Opportunity Announcements

Below are a few R01 Funding Opportunity Announcements (FOAs) that have been renewed with new FOA numbers or newly published within in the last few months.   Please see Funding Opportunities by Type for a complete listing of NCI funding Opportunities.
Due Dates: June 01 (OSR) Ι June 05 (Sponsor)
Amount & Project Period: Application Budgets not limited - 5 years (Note:  This may vary with some R01 announcements)
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Title & Link: Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults PA-17-110 (This one has a companion R21 FOA (PA-17-109)

Research Projects to Enhance Applicability of Mammalian Models for Translational Research PAR-17-245

Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research PAR-17-244
U01 NCI

NEW
June 05 All Ranks Federal Epidemiology

Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts

The purpose is to support of the core functions of Cancer Epidemiology Cohorts (CECs), as well as methodological research. This FOA is intended to support maintenance of existing CECs infrastructure and resource sharing with broader scientific communities.
Due Dates: June 01 (OSR) Ι June 05 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: 1.25M/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-233
R01 NIH

June 07 All Ranks Federal In vivo Cancer Imaging Systems

Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems

The purpose is to stimulate translation of scientific discoveries and engineering developments in imaging or spectroscopic technologies into methods or tools that address problems in cancer biology, risk of cancer development, diagnosis, treatment, and/or disease status. A distinguishing feature of each application will be formation of an academic-industrial partnership, which is a strategic alliance of investigators in academic, industrial, and any other entities who work together as partners to identify and translate a technological solution or mitigation of a cancer-related problem.
Due Dates: Applications Due:  June 05 (OSR) June 07 (Sponsor)
Additional 2017 Due Date:  Oct. 03
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-093
R01 NIH
NCI is a participating Institute

NEW
June 11 (LOI) All Ranks Federal Sleep Disparities

Mechanisms and Consequences of Sleep Disparities in the U.S.

NCI is particularly interested in understanding the mechanisms underlying how sleep deficiency or sleep disruption among minority and health disparity cancer populations may contribute to the disparity of cancer therapeutic outcomes such as progression-free survival, or overall survival through effect on therapeutic efficacy and quality of life during cancer treatment.
Due Dates: June 11 (Letter of Intent)
Application Due: Jul. 07 (OSR) Ι Jul. 11 (Sponsor)
Additional Due Dates:  July 11, 2018 & July 11, 2019
Amount & Project Period: Application budgets not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-234
Companion FOA: PAR-17-235 (R21)
R01 NCI

June 13 All Ranks Federal Cancer Communication

Innovative Approaches to Studying Cancer Communication in the New Media Environment

This FOA invites applications that seek to apply one or more innovative methodologies in communication research across the cancer control continuum, from prevention, early detection, diagnosis, treatment, and survivorship, to end of life.
Due Dates: June 09 (OSR) Ι June 13 (Sponsor)
Additional Due Date:  Oct. 11
Amount & Project Period: Application Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-249
Companion FOA: PAR-16-248 (R21)
Admin. Supplement NCI

NEW
June 15 See Below Federal Immunotherapy

Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy

The overarching goal is to support collaborative pilot projects to generate new ideas and approaches to reduce the incidence and/or severity of auto-inflammatory or autoimmune adverse events in the setting of cancer immunotherapy. In order to facilitate formation of multidisciplinary teams with expertise in mechanisms of cancer immunology/immunotherapy as well as immune tolerance and/or autoimmunity, teams that include (a) a current NCI grantee and a current NIAID grantee, or (b) a current NCI grantee and a current NIAMS grantee, are encouraged to propose collaborative pilot projects that utilize their complementary and synergistic expertise.
Due Dates: June 13 (OSR) Ι June 15 (Sponsor)
Amount: Max. $200,000 (Direct Costs)/yr. ($100,000 per collaborating PD/PI/IC), regardless of the number of collaborating units.
Performance Period: Must be w/in currently approved project period for existing parent award.
Both collaborating PDs/PIs must have at least one full year of active funding (excluding no-cost extension periods) remaining at time of anticipated award for a one year APRC request and two years of active funding (excluding no-cost extension periods) remaining at time of anticipated award for a two year APRC request.
An anticipated award date of August 15, 2017 can be used for this calculation.
Eligibility: Must hold eligible parent award:
Only PDs/PIs with active NCI, NIAID, or NIAMS funding of the eligible grant mechanisms (See FOA), in the areas of cancer immunotherapy, peripheral mechanisms of immune tolerance, or autoimmunity are eligible;
PDs/PIs may belong to the same or different departments w/in an institution, or from different institutions.
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-248


NEW
June 15 Junior Faculty Non-federal Neurobiology

Eppendorf & Science Prize for Neurobiology

This annual Prize is an international award honoring young scientists for their outstanding contributions to neurobiological research based on methods of molecular and cell biology. The winner and finalists are selected by a committee of independent scientists, chaired by Science's Senior Editor, Dr. Peter Stern.
Due Dates: June 15 (Sponsor) Entry form and additional submission materials must be submitted electronically through the prize management system.
Amount & Project Period:

The winner receives:
     >Prize money of US $25,000
     >Publication in Science of an essay by the winner about  
       his/her research
     >Full support to attend the Prize Ceremony held in  
       conjunction with the Annual Meeting of the Society for
       Neuroscience in the USA
     >An invitation to visit Eppendorf in Hamburg, Germany
     >Up to three finalists are honored, too!

Eligibility: Entrant must be a neurobiologist w/advanced degree received in the last 10 years and not older than 35 years of age;
Entrant's essay must describe contributions to neurobiological research based on methods of molecular and cell biology;
Entrant must have performed or directed work described in essay;
Research must have been performed during previous 3 years.
Link: Overview


NEW
June 16 All Ranks Federal Health IT

Health Information Technology (IT) to Improve Health Care Quality and Outcomes (R21)

This FOA invites grant applications for funding to conduct exploratory and developmental research grants for projects in the early and conceptual stages of development that will contribute to the evidence base of how health information technology (IT) improves health care quality and outcomes.
Due Dates: June 14 (OSR) Ι June 16 (Sponsor)
Additional Due Dates:  Standard dates
Amount & Project Period: $300,000 (TOTAL) - 2 years
Eligibility: All Ranks - Note:  Each PD/PI must devote a minimum of 20% annual full-time effort in each year of this project (i.e., at least 8 hours per week).
Contact: Office of Sponsored Research (x6804)
FOA Link: PA-17-246


NEW
June 20 All Faculty Ranks Non-federal Women's Cancers

The Foundation for Women's Wellness
2017 Research Awards

These research awards target early funding for small, short-term studies that hold promise for improving medical knowledge in leading female cancers.  Applications should only be for studies that are exploring basic, clinical or epidemiological lines of inquiry.
Due Dates: June 16 (OSR) Ι June 20 (Sponsor)
Amount & Project Period: $25,000 - 1 year
Eligibility: Must be an M.D. and/or Ph.D. with a faculty appointment (assistant professor, or higher)
Contact: Office of Sponsored Research (x6071)
Link: Research Awards


NEW
June 30 All Ranks Non-federal Children's Leukemia

Children's Leukemia Research Association (CLRA)
Research Grants

These research grants will be made for the most promising research into leukemia, in the hopes of isolating the causes and finding a cure for this dread disease.
Due Dates: June 28 (OSR) Ι June 30 (Sponsor)
Amount & Project Period: $30,000 -1 year
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
Link: Overview and Application


NEW
July 01 Postdocs Non-federal Career Development

The Helen Hay Whitney Foundation
2017 Research Fellowship

This fellowship supports early postdoctoral research training in all basic biomedical sciences.
Due Dates: June 29 (OSR) Ι July 01 (Sponsor)
Amount & Project Period: Yr. 01:  $52,000 (Stipend) + $1,500 (Allowance)
Yr. 02:  $54,000 (Stipend) + $1,500 (Allowance)
Yr. 03:  $57,000 (Stipend) + $1,500  (Allowance)
Eligibility: Must have obtained or be in final stages of obtaining a Ph.D., M.D., or equiv.
Must not have more than 1 year of postdoctoral research experience at deadline for submitting application and who have received a PhD (or D.Phil. or equiv.) no more than 2 years before the deadline, or M.D. degree no more than 3  years before the deadline.
No more than one application from a laboratory during each annual cycle.  Applications from different laboratories/supervisors at the same institution are allowed.
Contact: Office of Sponsored Research (X6804)
Link: Research Fellowships

NEW
July 03 All Ranks Non-federal Cutaneous

American Society for Dermatologic Surgery
Cutting Edge Research Grant Program (CERG)

Submission of well-conceived research projects that stimulate advancement of the practice of dermatologic surgery, the invention of new technologies or research projects that document the outstanding and high volume work of dermatologic surgeons are encouraged.  Specifically encouraged are proposals in the areas of depth of training, scope of practice, safety and efficacy as well as research with specific relevance in Core surgical procedures and techniques; Cutaneous oncology; and new technologies.
Due Dates: June 29 (OSR) Ι Jul. 03(Sponsor)
Amount & Project Period: $20,000  
Eligibility: All Ranks - PD/PI must be ASDS member
Contact: Office of Sponsored Research, x6804
Link: Overview Ι Application Site
R25 NIH
NCI is a participating Institute

NEW
July 04 (LOI) All Ranks Federal BD2K Educ. resources

BD2K Open Educational Resources for Skills Development in Biomedical Big Data Science

This FOA will support creative educational activities with a primary focus on Courses for Skills Development for biomedical researchers who need the requisite knowledge and skills to extract knowledge from biomedical Big Data.
Due Dates: Jul. 4 (Letter of Intent)
Applications Due:  Jul. 31 (OSR) Ι Aug. 02 (Sponsor)
Amount & Project Period: Not to exceed $200,000/yr. (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
RFA Link: RFA-HG-16-016
Companion RFAs: RFA-ES-16-002,  BD2K Mentored Career Development Award in
                             Biomedical Big Data Science for Clinicians
                             and Doctorally Prepared Scientists (K01)
RFA-ES-16-003,  BD2K Career Transition Award in Biomedical
                             Data Science for Intramural Investigators(K22)
RFA-LM-16-002, Predoctoral Training in Biomedical Big Data
                              Science (T32)

NEW
July 06 Faculty Ranks Non-federal Career Development

Damon Runyon Cancer Research Foundation
Innovation Award

The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances.
Due Dates: Jul. 03 (OSR) Ι Jul. 06 (Sponsor)
Amount & Project Period: $300,000 - 2 years (Stage 1 award will be for two years;  Stage 2 support for years 3 & 4 will be granted to those awardees who demonstrate progress on the proposed research during years 1 & 2 of the award.) 
Eligibility: Applicants must belong to one of the following categories: Tenure-track Assistant Professors w/in first four years of obtaining initial Assistant Professor position. (Cut-off date: July 1, 2013);
Clinical Instructors and Senior Clinical Fellows (in final year of sub-specialty training) holding an MD and pursuing a period of independent research before taking a tenure-track faculty position, and must have dedicated laboratory space and support of institution;
Not eligible are Research Assistant Professors, Research Associate Professors, Research Scientists and Postdoctoral Fellows; 
Applicants are expected to commit at least 80% of their full time effort to conducting research.
See award overview for additional eligibility details.
Contact: Office of Sponsored Research (x6804)
Links: Application Guidelines
U01 NCI

NEW
July 14 All Ranks Federal Solid Tumor Therapies

Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy

The purpose is to invite applications proposing studies to enhance pre-clinical in vitro and in vivo testing of NCI-prioritized molecularly targeted anti-cancer agents for use with radiation therapy combined with systemic chemotherapy. Studies should generate validated high-quality preclinical data on the effects of molecular therapeutics when added to standard-of-care therapies for solid tumors. The specific purpose is to provide a more rational basis for prioritizing those NCI-supported investigational new drugs or agents (INDs) most likely to have clinical activity with chemo-radiotherapy.
Due Dates: Jul. 12 (OSR) Ι Jul. 14(Sponsor)
Additional Due Date:  Nov. 14, 2017
Amount & Project Period: Max. $450,000/yr. (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-16-111
R01 NCI

NEW
July 18 (LOI) All Ranks Federal Inter-organelle Communication

Inter-organelle Communication in Cancer

The purpose of this FOA is to support research projects that examine how inter-organelle communication in cancer cells and/or tumor-associated cells affects cellular function, adaptation, and phenotypic plasticity.
Due Dates: Jul. 18 (Letter of Intent)
Applications Due:  Aug. 14 (OSR) Ι Aug. 16 (Sponsor)
Amount & Project Period: Application budgets not limited - 5  years
Eligibility: All Ranks
Contact: Office of Sponsored Research (x6804)
FOA Link: PAR-17-203
Companion FOA: PAR-17-204 (R21)
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org